{"name":"CleveXel Pharma","slug":"clevexel-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CVXL-0107","genericName":"CVXL-0107","slug":"cvxl-0107","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"CVXL-0107","genericName":"CVXL-0107","slug":"cvxl-0107","phase":"phase_2","mechanism":"CVXL-0107 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUXZhcWFuNDNhV0I1SmZmSXUzRFhLakp6emJRYUtOZWNtaEdBVlAxUUduV2g5emVMTUUtLTJDOFBiMXJTUTZOSjNzYlVSNGppcjJLZUpwY0F5SS1YaWVRc3RnUS00UXV4TFRtbGVLcXNic3RHbC1INUV2emw3QnR4dUZTSkFpZkxkdlFMQ09B?oc=5","date":"2022-06-13","type":"trial","source":"globaldata.com","summary":"Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQTEt6a3dydTgxVG83NzEySjVqU1JYXzV1cGlVQmw1ZkNremJZZmNDMDJtMUlmVjRqRWpXcGljWlBmRVVaVzEzX2JfYjBIUnRkakRHemJsbXFHUnhfYll0cDdsbThET3lHX2ZjRVlkcEVITVhrLWZRQjhhMmQ2WXdiVDZfazJIa1pqSzhRdnV2NEp4dnZQSjJHZW43UE15dFhDYjU2eXZBT29Wakpvb2dV?oc=5","date":"2014-09-23","type":"pipeline","source":"BioPharma Dive","summary":"Collaborating with Chinese pharma: Inside one company’s success story - BioPharma Dive","headline":"Collaborating with Chinese pharma: Inside one company’s success story","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}